HEADER MEMBRANE PROTEIN 12-JUN-06 2HAC TITLE STRUCTURE OF ZETA-ZETA TRANSMEMBRANE DIMER COMPND MOL_ID: 1; COMPND 2 MOLECULE: T-CELL SURFACE GLYCOPROTEIN CD3 ZETA CHAIN; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: TRANSMEMBRANE REGION (28-60); COMPND 5 SYNONYM: T-CELL RECEPTOR T3 ZETA CHAIN; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CD3Z, T3Z, TCRZ; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID KEYWDS TRANSMEMBRANE, ALPHA HELIX, MEMBRANE PROTEIN EXPDTA SOLUTION NMR NUMMDL 15 AUTHOR J.J.CHOU,K.W.WUCHERPFENNIG,J.R.SCHNELL,M.E.CALL REVDAT 4 20-NOV-24 2HAC 1 REMARK REVDAT 3 20-OCT-21 2HAC 1 REMARK SEQADV REVDAT 2 24-FEB-09 2HAC 1 VERSN REVDAT 1 31-OCT-06 2HAC 0 JRNL AUTH M.E.CALL,J.R.SCHNELL,C.XU,R.A.LUTZ,J.J.CHOU, JRNL AUTH 2 K.W.WUCHERPFENNIG JRNL TITL THE STRUCTURE OF THE ZETAZETA TRANSMEMBRANE DIMER REVEALS JRNL TITL 2 FEATURES ESSENTIAL FOR ITS ASSEMBLY WITH THE T CELL JRNL TITL 3 RECEPTOR. JRNL REF CELL(CAMBRIDGE,MASS.) V. 127 355 2006 JRNL REFN ISSN 0092-8674 JRNL PMID 17055436 JRNL DOI 10.1016/J.CELL.2006.08.044 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : NMRPIPE 1.0, XPLOR-NIH 2.11 REMARK 3 AUTHORS : FRANK DELAGLIO (NMRPIPE), CHARLES SCHWIETERS REMARK 3 (XPLOR-NIH) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: 426 INTRAMOLECULAR NOE RESTRAINTS, 46 REMARK 3 INTERMOLECULAR NOE RESTRAINTS, 42 DIHEDRAL ANGLE RESTRAINTS, 70 REMARK 3 RESIDUAL DIPOLAR COUPLING RESTRAINTS. REMARK 4 REMARK 4 2HAC COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-JUN-06. REMARK 100 THE DEPOSITION ID IS D_1000038128. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 303 REMARK 210 PH : 7.0 REMARK 210 IONIC STRENGTH : 20 MM SODIUM PHOSPHATE BUFFER REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 0.5-1.0 MM DISULFIDE CROSSLINKED REMARK 210 ZETA-ZETA DIMER U-15N,U-13C,85%- REMARK 210 2H. SODIUM DODECYL SULFATE (40 REMARK 210 MM) AND DODECYL PHOSPHOCHOLINE REMARK 210 (200 MM), 95% H2O, 5% D2O.; 0.5- REMARK 210 1.0 MM DISULFIDE CROSSLINKED REMARK 210 ZETA-ZETA DIMER U-15N,U-13C. REMARK 210 SODIUM DODECYL SULFATE (40 MM) REMARK 210 AND DODECYL PHOSPHOCHOLINE (200 REMARK 210 MM), 95% H2O, 5% D2O.; 0.5-1.0 REMARK 210 MM DISULFIDE CROSSLINKED ZETA- REMARK 210 ZETA DIMER, MIXED-LABEL. ONE REMARK 210 MONOMER: U-15N,U-2H. OTHER REMARK 210 MONOMER: NATURAL ABUNDANCE REMARK 210 ISOTOPES. SODIUM DODECYL SULFATE REMARK 210 (40 MM) AND DODECYL REMARK 210 PHOSPHOCHOLINE (200 MM), 95% H2O, REMARK 210 5% D2O.; 0.5-1.0 MM DISULFIDE REMARK 210 CROSSLINKED ZETA-ZETA DIMER U- REMARK 210 15N,U-13C. SODIUM DODECYL REMARK 210 SULFATE (40 MM) AND DODECYL REMARK 210 PHOSPHOCHOLINE (200 MM), 95% H2O, REMARK 210 5% D2O. 5% POLYACRYLAMIDE GEL. REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : GRADIENT-ENHANCED HNCA; 3D_15N REMARK 210 -SEPARATED_NOESY; 3D_13C- REMARK 210 SEPARATED_NOESY; STANDARD HSQC REMARK 210 AND TROSY-HSQC FOR D(NH) REMARK 210 COUPLINGS; 2D (CA)CONH REMARK 210 QUANTITATIVE JCH EXPERIMENT FOR REMARK 210 D(CAHA) COUPLINGS REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ; 600 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : CARA 1.5 REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 30 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 15 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 H1 ASP B -3 H SER B -2 1.34 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 2 SER A -2 90.62 50.99 REMARK 500 2 SER B 26 97.27 54.34 REMARK 500 2 ALA B 29 -169.47 47.19 REMARK 500 3 ARG B 27 -99.64 51.85 REMARK 500 4 SER A -2 29.29 49.89 REMARK 500 4 PHE A 25 -86.87 -84.82 REMARK 500 4 ALA B 29 -98.80 51.36 REMARK 500 5 SER A -2 19.13 48.34 REMARK 500 5 SER A 26 -21.73 -157.05 REMARK 500 6 SER A -2 177.95 53.11 REMARK 500 7 SER A 26 -45.80 -156.27 REMARK 500 7 SER A 28 29.18 47.64 REMARK 500 8 LYS A -1 10.47 -69.68 REMARK 500 8 SER A 28 -157.04 48.84 REMARK 500 8 ARG B 27 -137.87 53.69 REMARK 500 8 SER B 28 85.34 49.68 REMARK 500 9 SER A 28 27.99 49.70 REMARK 500 9 ALA B 29 -1.62 -159.19 REMARK 500 11 ARG B 27 -80.71 56.99 REMARK 500 12 ARG A 27 -157.97 51.46 REMARK 500 12 SER B 26 -10.86 -154.75 REMARK 500 12 SER B 28 73.44 50.65 REMARK 500 13 ALA A 29 -175.59 49.37 REMARK 500 13 ARG B 27 94.08 46.35 REMARK 500 14 ARG A 27 -116.52 45.75 REMARK 500 14 SER A 28 176.83 51.96 REMARK 500 14 ALA A 29 3.79 57.78 REMARK 500 14 ALA B 29 -118.76 47.85 REMARK 500 15 SER A 28 -175.50 56.78 REMARK 500 REMARK 500 REMARK: NULL DBREF 2HAC A -3 30 UNP P20963 CD3Z_HUMAN 28 60 DBREF 2HAC B -3 30 UNP P20963 CD3Z_HUMAN 28 60 SEQADV 2HAC SER A -2 UNP P20963 PRO 29 ENGINEERED MUTATION SEQADV 2HAC SER B -2 UNP P20963 PRO 29 ENGINEERED MUTATION SEQRES 1 A 33 ASP SER LYS LEU CYS TYR LEU LEU ASP GLY ILE LEU PHE SEQRES 2 A 33 ILE TYR GLY VAL ILE LEU THR ALA LEU PHE LEU ARG VAL SEQRES 3 A 33 LYS PHE SER ARG SER ALA ASP SEQRES 1 B 33 ASP SER LYS LEU CYS TYR LEU LEU ASP GLY ILE LEU PHE SEQRES 2 B 33 ILE TYR GLY VAL ILE LEU THR ALA LEU PHE LEU ARG VAL SEQRES 3 B 33 LYS PHE SER ARG SER ALA ASP HELIX 1 1 LYS A -1 PHE A 25 1 26 HELIX 2 2 LYS B -1 PHE B 25 1 26 SSBOND 1 CYS A 2 CYS B 2 1555 1555 2.02 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1